Physician profile
Daniel James Beless
NPI 1235163114
$955.12
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $329 · 2021: $190 · 2022: $14.45 · 2023: $44.38 · 2024: $16.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $60.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $60.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $416.13 | 2019-2021 | |
| Kci USA, INC. | $180.05 | 2019-2023 | 3m Cavilon, V.A.C. Dermatac |
| Aroa Biosurgery Incorporated | $159.08 | 2019-2020 | |
| Hydrofera LLC | $73.58 | 2021 | |
| Convatec INC. | $30.91 | 2023 | |
| Smith+Nephew, INC. | $29.24 | 2021-2024 | Grafix, Oasis |
| Melinta Therapeutics, LLC | $29.22 | 2019 | |
| Medela LLC | $20.81 | 2020 | |
| Hartmann USA, INC. | $16.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Beless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.